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The gut microbiota has been identified as a target of toxic metals and a potentially crucial 28 
mediator of the bioavailability and toxicity of these metals. In this study, we show that aluminium (Al) 29 
exposure, even at low-dose, affected the growth of representative strains from the human intestine via 30 
pure culture experiments. In vitro, Lactobacillus plantarum CCFM639 could bind Al on its cell surface 31 
as shown by electron microscopy and energy dispersive X-ray analysis. The potential of L. plantarum 32 
CCFM639 to reverse changes in human intestine microbiota induced by low-dose dietary Al exposure, 33 
was investigated using an in vitro colonic fermentation model. Batch fermenters were inoculated with 34 
fresh stool samples from healthy adult donors and supplemented with 86 mg/L Al and/or 109 CFU of L. 35 
plantarum CCFM639. Al exposure significantly increased the relative abundances of Bacteroidetes 36 
(Prevotella), Proteobacteria (Escherichia), Actinobacteria (Collinsella), Euryarchaeota 37 
(Methanobrevibacter), Verrucomicrobiaceae; and decreased Firmicutes (Streptococcus, Roseburia, 38 
Ruminococcus, Dialister, Coprobacillus). Some changes were reversed by the inclusion of L. 39 
plantarum CCFM639. Alterations in gut microbiota induced by Al and L. plantarum CCFM639 40 
inevitably led to changes in metabolite levels. The short-chain fatty acids (SCFAs) contents were 41 
reduced after Al exposure but L. plantarum CCFM639 could elevate their levels. SCFAs had positive 42 
correlations with beneficial bacteria, such as Dialister, Streptococcus, Roseburia, and negative 43 
correlations with Erwinia, Escherichia, Serratia. Therefore, dietary Al exposure altered the 44 
composition and structure of the human gut microbiota and this was partially mitigated by L. 45 
plantarum CCFM639. This probiotic supplementation is potentially a promising and safe approach to 46 
alleviate the harmful effects of dietary Al exposure. 47 
 48 
Keywords: aluminum toxicity; gut microbiota; lactic acid bacteria; probiotic; short chain fatty acids; 49 




1. Introduction  52 
The human gastrointestinal (GI) tract harbors a complex and dynamic population of 53 
microorganisms, including bacteria, archaea, fungi, protists, and viruses, among which bacteria are the 54 
major inhabitants [1]. The number of microorganisms in the human GI is approximately 1013–1014 that, 55 
together, have 300 times more genes than the human genome. The gut microbiota should, therefore, be 56 
considered as a virtual super-organ [2]. The gut microbiota plays important roles in human physiology 57 
and metabolism, including extraction of indigestible nutrients from food, synthesis of vitamins, 58 
maintenance of intestinal homeostasis, and modulation of the immune system [3]. The microbiota is 59 
dynamic and susceptible to changes in the host gut environment induced by exposure to exogenous 60 
substances, such as dietary factors, toxic metals, or probiotics [4,5]. In turn, the gut microbiome can 61 
affect host physiology by producing metabolites or transforming compounds in the gastrointestinal tract 62 
[2]. In the gut, short-chain fatty acids (SCFAs) are produced, mainly by anaerobic bacteria, from 63 
dietary components. These important metabolites have immunomodulatory and anti-inflammatory 64 
functions mediated via regulation of T cell homeostasis in the gut [6].  65 
Aluminum (Al) is the most abundant metal on earth. This metal is lightweight, strong, 66 
non-corroding and easily processed. For these reasons, it is widely used in daily life and by many 67 
industries: construction, aircraft, food production. Increases in Al contamination of the environment 68 
and accumulation in the food chain have led inevitably to continuous increases in human oral Al 69 
exposure. In several European countries, the daily Al exposure levels from food and water were 70 
reported to range from 0.2 - 1.5 mg/kg body weight (bw) per week in the general population [7]. The 71 
European Food Safety Authority (EFSA) has established a health-based guidance value of 1 mg/kg bw 72 
per week. Approximately 40% of ingested Al accumulates in the gut, which has been underestimated as 73 
a target organ for Al exposure [8]. Several studies have recently identified the gut microbiota as the 74 
first protective barrier against toxic metals, including Al. Accordingly, the gut microbiota may be a 75 
crucial mediator of the bioavailability of these metals [9,10]. For example, the gut microbiota may 76 
interact with metals via active absorption or passive binding [11]. Moreover, the gut microbiota and its 77 
metabolites, including SCFAs, can influence the transfer of metals into the body indirectly, which could 78 
affect intestinal barrier integrity [12]. Toxic metals may induce changes in the gut microbiota that lead 79 
to, or exacerbate, the toxicities associated with these metals.  80 
Probiotics are defined as live microorganisms that, when administered in adequate amounts, 81 
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confer a health benefit on the host [13] and are widely used in industrial probiotic foods and beverages 82 
[14]. They are known to have beneficial effects on the GI tract and nervous system [15,16], as well as 83 
having various other functions, such as reduction of lactose intolerance, modulation of immune system, 84 
alleviation of food allergy, decrease of blood pressure and prevention of osteoporosis [17,18]. It's worth 85 
mentioning that probiotics can reduce hazardous substances, such as toxic metal and acrylamide, in 86 
food products and the host [19-21]. Many probiotic strains are isolated from the gastrointestinal tract 87 
itself. Administration of probiotics can lead to changes in the levels of specific microbial species and 88 
SCFAs in the gut. For example, supplementation with Lactobacillus salivarius Ls-33 altered the 89 
relative abundance of Clostridium spp. in the feces of obese juveniles [22]. Ingestion of fermented milk 90 
containing Bifidobacterium animalis can reduce the abundance of some pathogenic bacteria and 91 
potentiate the production of SCFAs [23]. 92 
Studies in mice and fish reported that high-dose of Al exposure (up to ~200 mg/kg bw) affected 93 
the intestinal microbiota [10,24], but little has been reported about the effects of dietary Al exposure on 94 
the human gut microbiota at doses relevant to real-life exposure. L. plantarum CCFM639, a probiotic 95 
supplement, has been used previously to regulate changes in the intestinal microbiota induced by 96 
exposure to high doses of Al in an animal model [24]. It remains unclear whether administration of 97 
CCFM639 could reverse changes to the human intestinal microbiota induced by low-dose dietary Al 98 
exposure. In vitro gut fermentation models are powerful tools for investigating the impact of dietary 99 
components on the human gut microbiota [25]. These models can simulate the physiological 100 
environment of the gut, including pH, temperature, and anaerobic conditions [26]. Although not a 101 
complete substitute for human studies with in vivo models, in vitro analysis can be an accurate 102 
systematic approach to analyzing different parameters and end points in colonic fermentation [26]. 103 
Batch cultures constitute the simplest forms of in vitro models and have been used to investigate 104 
efficacy of probiotics and prebiotics [27-29]. In this study, we investigated the effects of dietary Al 105 
exposure and supplementation with the probiotic, L. plantarum CCFM639, on gut microbial 106 
composition and levels of SCFAs in healthy adults using an in vitro batch culture model. 107 
 108 
2. Materials and Methods 109 
2.1 Probiotic preparation 110 
L. plantarum CCFM639 (CGMCC 9664) was obtained from the Culture Collection of the Food 111 
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Microbiology department (CCFM), Jiangnan University (Wuxi, China) and cultured in De Man Rogosa 112 
Sharpe (MRS) broth at 37 ºC for 18 h with 2% inoculation. After three generations of activation, 20 mL 113 
of the fermentation broth was inoculated into 1L MRS for 18 h at 37 ºC. The cell pellets were collected 114 
by centrifugation at 8000×g and 4ºC for 5 min and then washed three times with sterile saline solution 115 
(NS; 0.85%) for the following experiments. 116 
  117 
2.2 Al exposure studies with pure bacterial cultures 118 
2.2.1 Pure bacterial cultures.  119 
In vitro experiments using pure cultures were done on representative strains to determine whether 120 
they were affected by Al. The following strains were evaluated and obtained from the in-house culture 121 
collection of the Quadram Institute Bioscience: L. plantarum CCFM639 (CGMCC 9664), 122 
Lactobacillus rhamnosus GG (ATCC 53103), Escherichia coli 1BO4 (isolated from human feces), 123 
Salmonella typhimurium ATCC SL1344, Bifidobacterium longum B78 (isolated from human feces), 124 
Clostridium perfringens NCTC3310 and Bacteroides thetaiotaomicron VP1-5482 (ATCC 29148). The 125 
two Lactobacillus strains were cultured in MRS broth and the E. coli and S. typhimurium were cultured 126 
in LB (Luria-Bertani) broth. All other strains were cultured in BHI (Brain Heart Infusion) broth. The 127 
strains were inoculated at a dose of 2% (v/v), approximately 106 CFU, in 100-well honeycomb plates 128 
supplemented with different concentrations of AlCl3·6H2O (43, and 86 mg/L Al ions) and incubated for 129 
24 or 48 h at 37ºC under anaerobic conditions (85% N2, 5% O2, 10% CO2, in a MACS-MG-1000 130 
controlled atmosphere cabinet, Don Whitley Scientific, UK). Absence of Al (0 mg/L) was used as the 131 
control group for each strain. Optical density (OD600) values were measured automatically every hour 132 
by a Magellan Microplate Reader (Tecan Life Sciences, Mannedorf, Switzerland). 133 
2.2.2 Electron microscopy and energy dispersive X-ray analysis.  134 
The Al binding assay [30] and samples for transmission electron microscopy (TEM) and scanning 135 
electron microscopy (SEM) were prepared as described previously [20]. After the Al binding assay, 136 
bacterial cells were harvested by centrifugation at 8000×g for 20 min, washed with phosphate-buffered 137 
saline solution (PBS) (pH 7.2), and resuspended in PBS. 25% glutaraldehyde was added to the bacterial 138 
suspension and the cells were left to fix for 1.5 h, then centrifuged and washed with sodium cacodylate 139 
buffer (0.05 M). The cell pellets were mixed at a 1:1 ration with molten 2% agarose, and then chopped 140 
into small pieces (about 1 mm3). These samples were left overnight in a 2.5% glutaraldehyde/0.05 M 141 
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sodium cacodylate buffer (pH 7.2) and then transferred to a Leica EM TP tissue processor (Leica 142 
Microsystems UK Ltd., Milton Keynes, UK). The samples were infiltrated with a resin (London Resin 143 
Ltd., London, UK) and ethanol mixture, and the tissue blocks of the samples were placed into gelatine 144 
capsules containing fresh resin and polymerized overnight at 60 ºC. The sections were cut using 145 
Reichert-Jung Ultracut E ultramicrotome, and examined and imaged using a FEI Tecnai G2 20 Twin 146 
TEM at 200 kV. The samples for SEM observation were prepared as following, after the Al binding 147 
assay, the bacterial cells were harvested and fixed with glutaraldehyde (2.5% v/v) for 4 h. The cells 148 
were then washed with PBS three times and dehydrated with graded alcohols. An identical volume of 149 
isoamyl acetate was used to displace the graded alcohols. The bacterial samples were lyophilized and a 150 
Hitachi S-3400N SEM was used to observe the cellular morphology. The TEM and SEM were 151 
equipped with energy dispersive X-ray (EDX) microanalysis systems and the elemental composition of 152 
the selected areas observed using the electron microscope was analyzed. 153 
 154 
2.3 In vitro colonic fermentation models  155 
Fecal samples were collected from healthy volunteers with no diagnosed gastrointestinal diseases 156 
and no history of probiotic or antibiotic usage within the previous 4-week period. The study was 157 
approved by the Institute of Food Research (now Quadram Institute Bioscience) Human Research 158 
Governance committee (IFR01/2015). Informed consent was obtained from all participating volunteers. 159 
The trial was registered at http://www.clinicaltrials.gov (NCT02653001). Fresh fecal samples were 160 
collected every morning between 6:00 and 10:00 and processed within 1 hour. Specifically, 15 g of 161 
feces from central area were suspended in sterile deoxygenated phosphate-buffered saline PBS (pH 7.0) 162 
at a ratio of 1:10 and homogenized using a Stomacher 400 circulator (Seward Ltd., Worthing, West 163 
Sussex, UK) at 230 rpm for 45 s [31]. The processed fecal samples were then used for in vitro colonic 164 
fermentation (Fig.1). 165 
To each vessel (300 mL), 15 mL of the processed fecal sample and 135 mL of sterile basal growth 166 
medium (BGM) were added. Composition of BGM media included peptone water 2 g/L, yeast extract 2 167 
g/L, NaCl 0.1 g/L, K2HPO4 0.04 g/L, KH2PO4 0.04 g/L, MgSO4.7H2O 0.01 g/L, CaCl2.6H2O 0.01 g/L, 168 
NaHCO3 2 g/L, Tween 80 2 mL, glucose 10 g/L, vitamin K1 10 μL, cysteine HCl 0.5 g/L, bile salts 0.5 169 
g/L (pH 7.0) [31]. The experimental groups were designated as follows: (A) control (no addition), (B) 170 
LP group (109 CFU of L. plantarum CCFM639 added), (C) Al group (86 mg/L of Al ion added ) and (D) 171 
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Al + LP group (109 CFU of L. plantarum CCFM639 and 86 mg/L of Al added). There were three 172 
replicate vessels per experimental group. The vessels were maintained at 37ºC by a circulating water 173 
jacket and supplied with nitrogen to maintain an anaerobic environment. The pH value was maintained 174 
at 6.8 using Fermac 260 pH control units (Electrolab Biotech Ltd., Tewkesbury, Gloucestershire, UK). 175 
15 mL aliquots were collected from each vessel for further analysis after 0, 8, and 24 h. Three 176 
four-vessel experiments were conducted in total using feces from 3 different donors. 177 
At each sampling time, the total number of bacteria and the number of Bacteroides, 178 
Bifidobacterium, Clostridium, Lactobacillus, and Enterobacter spp. in each vessel were estimated by 179 
colony counts using Wilkins Chalgren, Bacteroides, Beerens, Clostridia, MRS, and McConkey 180 
selective agar plates, respectively (Oxoid, Basingstoke, Hampshire, UK). The two Lactobacillus strains 181 
were incubated at 37ºC for 24 h in aerobic condition, while other strains were cultured in anaerobic 182 
conditions at the same temperature for 24 h or 48 h 183 
 184 
2.4 Evaluation of the microbiota  185 
At each sampling time 12 mL of fermentation broth from each vessel was separated by 186 
centrifugation at 13,000×g and 4ºC for 10 min. The supernatant was removed and the pellets 187 
resuspended in 1 mL of PBS. This step was repeated three times, after which time DNA was extracted 188 
from each pellet using the Fast DNA Spin Kit for Soil (Qbiogene, Carlsbad, California, USA) 189 
according to the manufacturer's instructions. The bacterial 16S rRNA gene was amplified using the 190 
forward primer 515F (5´-barcode-GTG CCA GCM GCC GCG G-3´) and the reverse primer 907R 191 
(5´-CCG TCA ATT CMT TTR AGT TT-3´) [32]. Amplicons were added, 8-base barcoded, and an 192 
Illumina MiSeq sequencer used for sequencing. The original data files were analyzed using the QIIME 193 
platform (version 1.17). UPARSE was used for cluster analysis of operational taxonomic units (OTUs), 194 
and UCHIME was used for identification and removal of chimeric sequences. OTU strain types were 195 
identified using the Ribosomal Database Project (RDP) Naive Bayes classifier. 196 
 197 
2.5 Quantification of SCFAs 198 
At each sampling time (0, 8, and 24 h) a 1-mL aliquot of fermentation broth was collected from 199 
each vessel and centrifuged at 4000×g and 4ºC for 15 min. Subsequently, 900 μL of supernatant was 200 
added to 100 μL of NMR buffer (100 ml D2O containing 0.26 g NaH2PO4, 1.41 g K2HPO4, 0.1% NaN3, 201 
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and 1 mM deuterated trimethyl silylpropionate (TSP) as a reference compound) before 1H NMR 202 
spectroscopic analysis of the SCFAs, as described in a previous study [31]. The metabolites were 203 
quantified using the software Chenomx® NMR Suite 7.0TM. It is a specialised software that directly 204 
quantifies compounds from signals in the 1H NMR spectra. It relies on the principle that the NMR 205 
signal area of a compound is directly proportional to its concentration. We use an internal reference 206 
called TSP that we add to the buffer solution (1 mM TSP) to quantify all the compounds detected in 207 
Chenomx. This obviates the need for a calibration curve or further calculations, as the software 208 
provides the data directly. 209 
2.6 Data analysis 210 
One-way analysis of variance and nonparametric tests were used to analyze the results with three 211 
repetitions. Data were expressed as means ± standard deviations (SD). The analyses were performed 212 
using Origin 8.6 software (Originlab, USA). P values of < 0.05 indicated a statistically significant 213 
difference. Alpha diversity and beta diversity of the gut microbiota were analyzed based on the levels 214 
of OTUs. Moreover, a linear discriminate analysis effect size (LEfSe) was applied to determine the 215 
significance of differences in the relative abundances of gut microbiota between the control and the Al 216 
only groups and between the Al and Al + LP groups, using the Galaxy website 217 
(http://huttenhower.sph.harvard.edu/galaxy?tdsourcetag=s_pctim_aiomsg) [33]. A parametric 218 
Kruskal-Wallis test and linear differential analysis (LDA) were used to identify significant differences 219 
and estimate their effect sizes. The results of LDA classification can be graphically visualized by 220 
projecting the classes (preferably three or more) into the space of canonical variates, or discriminant 221 
functions [33]. Results were considered significant at an adjusted P value of less than 0.05 and an LDA 222 
score of at least 2.0. The association between the gut microbiota and SCFAs was explored via the 223 
Pearson’s correlation coefficient (two-tailed), one of the most common used correlation coefficient, 224 
which was plotted as a heat map using the R package "corrplot". 225 
 226 
3. Results  227 
3.1 Effects of Al exposure on pure cultures 228 
The Al ion concentrations of 43 and 86 mg/L were selected according to the total dietary Al 229 
exposure as assessed in several European countries [7]; these two Al exposure concentrations had little 230 
or no effect on the growth of L. plantarum, L. rhamnosus, Ba. thetaiotaomicron, E. coli, and S. 231 
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typhimurium (Figs. 2A, B, D-F). The growth of Bi. longum was significantly reduced at an Al 232 
concentration of 43 mg/L (P < 0.05); at 86 mg/L the lag and logarithmic phases were greatly extended 233 
and cultures did not reach the stationary period, even after 48 h (Fig. 2C). Growth of C. perfringens in 234 
the absence of Al entered the logarithmic phase quickly, and the stationary phase was achieved within 235 
10 h. The trend in the growth curve in cultures exposed to 43 mg/L of Al ion was similar to that of 236 
control cultures, but the OD600 level in the stationary phase was significantly increased in the presence 237 
of Al (P < 0.05). Interestingly, at an Al concentration of 86 mg/L, the lag phase was extended to 238 
approximately 10 h, followed by a short logarithmic phase and a stable period with the highest OD600 239 
reading (Fig. 2G). These results indicate that Bi. longum and C. perfringens were sensitive to Al, 240 
whereas L. plantarum, Ba. thetaiotaomicron, E. coli, and S. typhimurium exhibited good tolerance to 241 
Al. 242 
We examined the morphology of CCFM639 using electron micrographs after Al binding (Fig. 3). 243 
SEM revealed obvious Al deposits on the cell surface, with no morphological changes after Al binding 244 
(Fig. 3B). TEM revealed that Al was deposited on cell surfaces, but that it did not enter the cells (Fig. 245 
3D). EDX did not detect Al in the control cells (Fig. 3E) but revealed a distinct Al peak in the 246 
Al-treated samples (Fig. 3F), thus demonstrating the association of Al with the cells.  247 
 248 
3.2 Effects of Al and L. plantarum CCFM639 on the gut microbiota in an in vitro colon model  249 
3.2.1 Growth of specific groups of bacteria 250 
The analyses of pure cultures revealed that an Al concentration of 86 mg/L had greater effects on 251 
the representative strains than the lower concentration. Accordingly, 86 mg/L Al was selected for the in 252 
vitro colonic fermentation experiments. In the fermentation study, no significant differences were 253 
observed among the four vessels with respect to the total number of bacteria and the abundance of 254 
Lactobacillus spp. (P > 0.05) (Table 1). However, compared with the control, the number of 255 
Bacteroides increased significantly within 24 h in the Al-only treatment (P < 0.05), while 256 
co-inoculation of Al and L. plantarum CCFM639 (Al+ LP) prevented this increase. Bifidobacterium 257 
spp. were highly sensitive to treatment of both Al only and Al + LP; compared with the control, the 258 
abundance of Bifidobacterium spp. was significantly reduced at 8 and 24 h with both of these 259 
treatments, but the reduction was not as great when Al was added together with L. plantarum 260 
CCFM639 at 8 h (P < 0.05). Notably, L. plantarum CCFM639 administration resulted in an increased 261 
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abundance of Bifidobacterium species at 8 h in the absence of Al (P < 0.05). For Clostridium spp., Al 262 
only significantly promoted growth at both 8 and 24 h, whereas co-treatment with L. plantarum 263 
CCFM639 significantly reversed these trends (P < 0.05), giving counts which were more similar to the 264 
untreated controls. Moreover, compared with the control, L. plantarum CCFM639 significantly 265 
reduced the numbers of Clostridia at 24 h in the absence of Al exposure. The levels of 266 
Enterobacteriaceae were also significantly increased after Al exposure at 24 h, whereas co-inoculation 267 
with L. plantarum CCFM639 reduced this population so that it was not significantly different to the 268 
control (P < 0.05). Overall, L. plantarum CCFM639 has a mitigating effect on the Al-induced 269 
imbalance in the microbiota, particularly with regards to Bifidobacterium and Clostridia.  270 
 271 
3.2.2 Intestinal microbiota diversity and composition 272 
Shannon indices revealed no significant differences between the four treatment groups at both the 273 
8 h and 24 h time points (Fig. 4A). However, the Principal coordinates analysis (PcoA) plot (Fig. 4B) 274 
revealed clear distinctions between the control, Al, and Al + LP groups indicating significant 275 
differential clustering of the microbiota composition at 24 h; PC1 and PC2 explained 38.2% and 17.3% 276 
of the variance, respectively.  277 
We further examined compositional changes in the gut microbiota at the phylum, class, order, 278 
family and/or genus levels using high-throughput amplicon sequencing (Fig. 4C, 4D). After 24 h, the 279 
relative abundances of the five predominant bacterial phyla - Firmicutes, Actinobacteria, Euryarchaeota, 280 
Bacteroidetes, and Proteobacteria - were 56.10%, 35.70%, 4.10%, 3.12%, and 0.92%, respectively, in 281 
the control group (Fig. 4C). Al exposure enhanced the abundances of Proteobacteria (24 h, 6.90%) and 282 
Bacteroidetes (at 8 h only, 12.96%) and reduced the abundance of Firmicutes (24 h, 46.67%), whereas 283 
these changes were not as large in the Al + LP group. Interestingly, the LP group exhibited an increase 284 
in the abundance of Actinobacteria (24 h, 40.84%) and a decrease in the abundance of Bacteroidetes 285 
(24 h, 1.48%), compared with the control.  286 
At the family and genus levels, various taxa were significantly decreased in the Al only group 287 
compared with the control (P < 0.05); these included Streptococcaceae, Streptococcus, 288 
Lactobacillaceae, Roseburia, Dialister, Coprobacillus, and Ruminococcus. In contrast significant 289 
increases were observed in Enterobacteriaceae, Escherichia, Erwinia, Serratia, Coriobacteriaceae, 290 
Collinsella, Actinomyces, Odoribacteraceae, Porphyromonadaceae, Rikenellaceae, Barnesiellaceae, 291 
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Prevotellaceae, Prevotella, Clostridiaceae, Verrucomicrobiaceae, Methanobacteriaceae, 292 
Methanobacteria, and Methanobrevibacter (Fig. 5; Table S1). Compared to the Al group, significant 293 
increases in the relative abundances of Lactobacillaceae, Lactobacillus, Pediococcus, Weissella and 294 
Bacillaceae, and decreases in the abundances of Odoribacteraceae, Porphyromonadaceae, 295 
Parabacteroides, Erysipelotrichaceae, Lachnospiraceae, Bacteroidales, Rikenellaceae, 296 
Coriobacteriaceae, Collinsella, Eggerthella, and Verrucomicrobiaceae were observed in the Al + LP 297 
group (Fig. 5; Table S1).  298 
 299 
3.2.3 Significant changes in the composition of intestinal microbiota 300 
At the genus level, the abundances of Bifidobacterium, Lactobacillus, Pediococcus, Streptococcus, 301 
Dialister, Roseburia, and Ruminococcus spp. were significantly reduced in the Al only group, 302 
compared with the control, whereas the abundances of Clostridium, Escherichia, and Erwinia spp. 303 
were significantly increased (Fig. 6, P < 0.05). In the Al + LP group, L. plantarum CCFM639 304 
administration significantly increased the abundances of Lactobacillus and Pediococcus (P < 0.05), to a 305 
greater extent than in the LP group. Moreover, L. plantarum CCFM639 treatment caused a large 306 
decrease in the abundance of Streptococcus, both alone and in the presence of Al (P < 0.05).  307 
 308 
3.2.4 Impact of Al and CCFM639 on SCFA levels 309 
Al exposure and L. plantarum CCFM639 treatments had little effect on levels of SCFA after 8 h, 310 
except for a decrease in acetate in all three treatment groups compared to the control (Fig. 7). After 24 311 
h, however, the levels of acetate, butyrate, and propionate all decreased significantly in the Al-only 312 
group, whereas co-treatment with L. plantarum CCFM639 significantly alleviated the decrease of 313 
butyrate and propionate (P < 0.05). Interestingly, butyrate levels were also increased significantly by 314 
treatment with L. plantarum CCFM639 only at 24 h (P < 0.05).  315 
 316 
3.2.5 Correlations of the gut microbiota with SCFAs  317 
Pearson  correlation analysis indicated negative correlations between levels of the three SCFAs 318 
and Actinomyces, Bacteroidetes, Bacteroidia, Bacteroidales, Enterobacteriaceae, Erysipelotrichales, 319 
Erwinia, Escherichia, Gammaproteobacteria, Odoribacteraceae, Parabacteroides, Porphyromonadaceae, 320 
Prevotella, Prevotellaceae, Proteobacteria, Serratia, Verrucomicrobia and Verrucomicrobiaceae 321 
12 
 
(Pearson  rank correlation coefficient r: -0.50 to -0.95, Fig. 8). Positive correlations between the 322 
SCFAs levels and Coprobacillus, Dialister, Roseburia, Ruminococcus, Streptococcus and 323 
Streptococcaceae were also observed (P < 0.05; r: 0.49 to 0.99). Moreover, for Bacilli, Lactobacillales, 324 
Lactobacillaceae, Lactobacillus and Pediococcus, there were positive correlations with butyrate and 325 
propionate levels, but negative correlations with acetate level. However, Collinsella and 326 
Erysipelotrichceae showed positive correlations with acetate and butyrate levels. Interestingly, negative 327 
correlations between Bacilli, Lactobacillales, Lactobacillaceae, Lactobacillus, Pediococcus, 328 
Veillonellaceae, Veillonella and Bacteroidetes, Bacteroidia, Bacteroidales, Erysipelotrichaceae, 329 
Odoribacteraceae were also observed (P < 0.05). 330 
 331 
4. Discussion 332 
Previous studies have focused largely on Al toxicity to the liver, kidney, and brain in mice 333 
[34,21,30], but there have been few studies on the effects of dietary Al on the human gut microbiota at 334 
doses relevant to real-life exposure. However, the gut microbiota plays important roles in human 335 
physiology and metabolism, and Al-induced changes in these bacteria may be an important mechanism 336 
for Al toxicity. Thus, it is necessary to explore the effects of dietary Al on the human gut microbiota. Al 337 
has toxic effects on microorganisms, mainly via competition with Fe and Mg, and by binding to DNA, 338 
ATP enzymes, or enzyme substrates [35]. Analyses of pure cultures showed that the effects of Al on 339 
microorganisms were largely strain-dependent. A previous study also found an approximately 10-fold 340 
difference in Al resistance abilities among strains [30]. Strains of L. rhamnosus, L. plantarum, E. coli, S. 341 
typhimurium, and Ba. thetaiotaomicron were relatively resistant to Al at physiologically-relevant levels 342 
(86 mg/L). In contrast, Bi. longum was sensitive to Al, and its growth was significantly reduced. In 343 
contrast, Al promoted the growth of C. perfringens, possibly because Al can form a complex with 344 
superoxide to catalyze the reduction of Fe3+ to Fe2+ and promote the use of Fe [36]. Fe is a 345 
critically-important nutrient for Clostridium spp., which are strict anaerobes. These results were 346 
consistent with the results from intestinal microbiota analyses under in vitro colonic fermentation 347 
conditions. According to the results of our in vitro pure cultures and previous studies, we hypothesized 348 
that the ingestion of a low dose of Al would inevitably affect the gut microbiota [24,10]. The probiotic 349 
L. plantarum CCFM639 had an excellent Al-binding ability in our previous study [30]. Here, EM 350 
observation and EDX analysis confirmed that Al was bound to the surfaces of L. plantarum CCFM639 351 
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cells, thus reducing the Al concentration in the fermentation broth and reducing the toxic effects of this 352 
metal on the gut microbiota.  353 
Batch cultures constitute the simplest forms of in vitro models used to study the human gut 354 
microbiota. These are usually composed of a single bioreactor vessel with basal media, incubated under 355 
constant physiological temperature (37 oC), pH (6.8), and anoxic atmosphere (N2) with short period of 356 
incubation (usually 24-48 h) [37]. The reasons for short incubation time are nutrient depletion and 357 
accumulation of inhibitory bacterial metabolites, leading to a rapid progression to the stationary phase 358 
[38]. In vitro colonic models do not always provide accurate models of what occurs in vivo, as they 359 
lack an epithelial mucosa, host immunological interactions, and neuroendocrine system functionality 360 
[39]. However, they enable changes in the microbiota to be monitored, in terms of numbers and 361 
metabolism, attributable to the addition of exogenous substance, or disease state that is to be assessed. 362 
The single vessel batch culture in this study are a quick, simple, and cost-effective means of studying 363 
the gut microbiome [37]. They have been widely used in investigating the effects of probiotics, 364 
prebiotics or other food ingredients on the composition and metabolism of the human gut microbiota 365 
[29,40]. 366 
Alpha diversity analysis revealed no significant differences among the control, LP, Al and Al + LP 367 
groups in overall richness of gut microbiota. Possibly, a low-dose dietary Al exposure or ingestion of a 368 
single probiotic may not have a significant effect on the overall richness but may lead to changes in the 369 
relative abundances of specific families or genera [41]. Our results indicated an increase in abundances 370 
of the genera Escherichia, Erwinia, Serratia, Collinsella, Prevotella, Clostridium, Methanobacteria, 371 
and Methanobrevibacter and decreases in abundances of the genera Streptococcus, Roseburia, 372 
Ruminococcus, Dialister, and Coprobacillus in Al group. Similar changes were also observed in mice 373 
exposed to other toxic metals, such as Cd, Pb, and Cr [42]. Some changes in microbial abundance 374 
induced by Al exposure, namely in the phyla Bacteroidetes, Actinobacteria, and Verrucomicrobia and 375 
the family Lactobacillaceae, were restored to control levels by the addition of L. plantarum CCFM639 376 
in the Al + LP treatment. Wu et al. reported that the probiotic L. plantarum TW1-1 could also modify 377 
Cr-induced changes in the structure of the gut microbiota through a process called ‘gut remediation’ 378 
[42]. 379 
In humans, Bacteroides, Bifidobacterium, Clostridium, and Ruminococcus spp. are the 380 
predominant genera of anaerobic bacteria in the gut microbiota, followed by facultative anaerobes such 381 
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as Escherichia, Enterobacter, Enterococcus, and Lactobacillus. An increase in the abundance of 382 
Proteobacteria is associated with disrupted anaerobiosis, an indicator of gut dysbiosis [43]. Al exposure 383 
dramatically increased the relative abundances of organisms in the phylum Proteobacteria, including 384 
the class Gammaproteobacteria, family Enterobacteriaceae, and genera Escherichia, Erwinia, and 385 
Serratia. Proteobacterial blooms have been observed in humans with low-level or severe intestinal 386 
inflammation, including those with inflammatory bowel disease (IBD), necrotizing enterocolitis, or 387 
irritable bowel syndrome [44]. High levels of the class Gammaproteobacteria have been observed in 388 
pregnant women with IBD and their newborns [45]. The abundance of Enterobacteriaceae, which has a 389 
relatively higher oxygen tolerance, is low in the gut. However, gut inflammation is particularly 390 
conducive to proliferation of Enterobacteriaceae [46]. L. plantarum CCFM639 administration partially 391 
counteracted the Al-induced increase in Enterobacteriaceae (Table 1), which may be due to L. 392 
plantarum CCFM639 secreting SCFAs that affect the growth of Enterobactericeae [47]. Wei et al., 393 
found that proliferation of the genus Serratia was related to downregulation of gut immune responses 394 
in fungus-infected mosquitoes [48]. Serratia marcescens, an opportunistic pathogen, was significantly 395 
more abundant in patients with Crohn’s disease (CD) compared with healthy individuals [49]. The 396 
abundance of Erwinia spp. increased in patients with systemic sclerosis, an autoimmune 397 
gastrointestinal disease associated with high morbidity and mortality [50]. Another study demonstrated 398 
that Al had pro-inflammatory effects in both animals and humans [51]. 399 
The relative abundances of Porphyromonadaceae and Odoribacteraceae (Phylum Bacteroidetes) 400 
and of Coriobacteriia, Coriobacteriales, Coriobacteriaceae, and Collinsella (Phylum Actinomycetales) 401 
were significantly more abundant in the Al-only treatment compared with the control, but became less 402 
abundant after L. plantarum CCFM639 supplementation in the Al + LP treatment. The genus 403 
Odoribacter has been identified in the inflammatory processes associated with IBD, CD, ulcerative 404 
colitis, and colon cancer [52]. Collinsella spp. correlated strongly with the production of the 405 
proinflammatory cytokine IL-17A and chemokines [53]. In addition, an increased abundance of 406 
Collinsella may reduce tight junction protein expression and increase gut permeability, thus increasing 407 
transfer of toxic metals through the gut barrier. Furthermore, the families Bacteroidaceae, 408 
Prevotellaceae, and Rikenellaceae, and the genus Prevotella, were also in greater abundance in the 409 
Al-only group, compared with the control. Bacteroidaceae spp. are known to promote secretion of 410 
IL-17 by Th17 cells, thus triggering inflammatory responses [54]. An increase in the abundance of 411 
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Bacteroides may increase the secretion of the proinflammatory cytokines IL-6 and IL-23 [55]. The 412 
abundances of other members of the phylum Actinomycetales, namely Actinomycetales, 413 
Actinomycetaceae, and Actinomyces, were also in greater abundance in the Al-only group, compared 414 
with the control, while the abundance of Eggerthella was lower in the Al + LP group compared with Al 415 
only group. Eggerthella has been positively associated with the frailty index in elderly people [56]. 416 
Also, Wang et al. reported that a higher abundance of Eggerthella spp., which may be pathogenic, was 417 
related to abnormalities in glutamate and bile acid metabolism in the guts of autistic children [57]. Thus, 418 
L. plantarum CCFM639 may alleviate Al toxicity by regulating the abundances of Bacteroidetes and 419 
Actinomycetales spp.  420 
Al exposure and L. plantarum CCFM639 administration had dramatic effects on the relative 421 
abundances of Firmicutes spp. Al exposure decreased the relative abundance of the phylum Bacilli, 422 
compared with the control, including the orders Lactobacillales, families Streptococcaceae and 423 
Lactobacillaceae, and the genus Streptococcus, many of which are considered beneficial. In contrast, L. 424 
plantarum CCFM639 treatment led to increases in Bacilli, including the orders Lactobacillales and 425 
Bacillales; family Lactobacillaceae; and genera Lactobacillus, Pediococcus, and Weissella. Abundances 426 
of the genera Roseburia and Ruminococcus were lower in the Al group compared with the control. 427 
Roseburia spp. produce SCFAs, particularly butyrate. A decrease in the abundance of Roseburia has 428 
often been associated with reduced production of SCFAs and negative effects on the gut microbiota 429 
[58]. Decreased relative abundances of Veillonella and Streptococcus have also been observed in the 430 
gut microbiota of patients with autism spectrum disorder, and Streptococcus has been negatively 431 
associated with inflammation [59]. The subclass Erysipelotrichia has been correlated positively with 432 
the levels of alpha tumor necrosis factors (TNF-α) and inflammation [60]. Therefore, Al exposure led 433 
to increases in the relative abundances of some harmful bacteria and decreases in the relative 434 
abundances of beneficial bacteria, whereas L. plantarum CCFM639 administration had the opposite 435 
effects and, when added together with Al, was often able to mitigate its effects. 436 
Changes in gut microbiota composition induced by Al and L. plantarum CCFM639 led to changes 437 
in metabolite levels. We identified positive correlations between beneficial bacteria, such as Dialister, 438 
Streptococcus, Roseburia, and levels of SCFAs; and negative correlations between Erwinia, 439 
Escherichia, Prevotellaceae, Serratia and levels of SCFAs. These fatty acids exert anti-inflammatory 440 
functions on various gut immune cells [6], thus decreases in SCFA-producing species may induce a 441 
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shift to an inflammation-promoting microbiota. Various bacteria in the Phylum Firmicutes, including 442 
Coprococcus, Roseburia, Ruminococcus and Dialister, produce butyrate. Accordingly, a decrease in 443 
Firmicutes spp. decreases the production of butyrate [61]. Al exposure led to reductions in these 444 
SCFA-producing strains, which corresponded to reductions in SCFAs production. Consistent with our 445 
hypothesis, the levels of the three main SCFAs decreased significantly in the Al-only group, whereas 446 
co-L. plantarum CCFM639 administration significantly elevated the levels of butyrate and propionate. 447 
Therefore, L. plantarum CCFM639 counteracted the Al-induced changes in human gut microbiota 448 
possibly due to its Al binding ability and metabolites [24]. Initial Al sequestration of L. plantarum 449 
CCFM639 could lead to a decrease of Al level in intestine, thereby counteracting the Al-induced 450 
changes in gut microbiota. Moreover, some metabolites of CCFM639, such as SCFAs, may increase 451 
beneficial bacteria and decrease harmful bacteria, thus altering the composition of the gut microbiota 452 
and therefore the total bacterial metabolite profile. 453 
 454 
5. Conclusions 455 
In conclusion, daily dietary Al exposure affects the diversity and community structure of the 456 
human gut microbiota, leading to increases in the relative abundances of harmful bacterial species such 457 
as Escherichia, Erwinia, Serratia and Odoribacteraceae, and decreases in the abundances of beneficial 458 
bacterial species such as Streptococcus, Lactobacillales, and Veillonellaceae. The levels of SCFAs were 459 
reduced after Al exposure. However, inclusion of the probiotic L. plantarum CCFM639, which binds 460 
Al, mitigated some of the negative changes described above. L. plantarum CCFM639 may alleviate Al 461 
toxicity by regulating gut microbiota and the levels of SCFAs. This probiotic supplement is potentially 462 
a promising and safe approach to the alleviation of the harmful effects of daily dietary Al exposure. 463 
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Table 1. Effects of Al and L. plantarum CCFM639 on the predominant microbiota in a colonic fermentation model 670 
Predominant 
microbiota  
Fold of control, ±SD 
8 h  24 h 
Control LP Al Al + LP  Control LP Al Al + LP 
Total anaerobes 1.00 a 1.07±0.10 a 0.88±0.09 a 1.07±0.23 a  1.00 A 0.99±0.18 A 0.97±0.17 A 1.04±0.13 A 
Bacteroides 1.00 a 1.04±0.09 a 1.16±0.23 a 1.05±0.10 a  1.00A 0.99±0.11A 1.39±0.19B 1.03±0.16A 
Bifidobacterium 1.00a 1.14±0.06b 0.20±0.04c 0.52±0.07d  1.00A 0.98±0.10A 0.31±0.05B 0.46±0.07B 
Clostridium 1.00a 0.94±0.17a 4.94±0.66b 1.09±0.16a  1.00A 0.62±0.07B 3.14±0.24C 0.95±0.11A 
Lactobacillus 1.00 a 0.99±0.07 a 0.91±0.10 a 1.01±0.06a  1.00 A 0.94±0.04 A 0.97±0.02 A 0.98±0.14 A 
Enterobacteriaceae 1.00 a 1.05±0.13 a 1.23±0.10 a 0.99±0.23 a  1.00A 0.92±0.05A 1.47±0.15B 1.15±0.12A 




Figure Legends 673 
Figure 1. The flow chart of the in vitro colonic fermentation models. 674 
A: The illustration of colonic fermentation model. B: The flow diagramme indicating 675 
sampling points and analysis. Co., control; LP, L.plantarum; Al, Aluminium 676 
 677 
Figure 2. Effects of Al exposure on the growth of representative strains in pure in 678 
vitro culture.  679 
The asterisks indicate a statistically significant difference relative to the control group 680 
(P < 0.05). 681 
 682 
Figure 3. Scanning electron microscopy (SEM), transmission electron microscopy 683 
(TEM), and energy dispersive X-ray (EDX) analyses of L. plantarum CCFM639 684 
before and after Al binding.  685 
A, C, and E depict the SEM, TEM, and EDX results of the untreated biomass. B, D, 686 
and F depict the SEM, TEM, and EDX results of biomass after Al binding. Scale bar 687 
= 100 nm. 688 
 689 
Figure 4. Effects of Al and L. plantarum CCFM639 supplementation on gut 690 
microbiota diversity and relative abundance.  691 
A: Shannon index analysis of microbial alpha diversity. B: Principal coordinates 692 
analysis (PCoA) of differences in the microbial community structures among the four 693 
groups. C: Relative abundances of the gut microbiota at the phylum level after 8 and 694 
24 h, respectively. D: Relative abundances of the gut microbiota at the class, family 695 
and genus levels after 8 and 24 h, respectively. 696 
 697 
Figure 5. Comparison of different compositions of gut microbiota after Al exposure 698 
and L. plantarum CCFM639 supplementation based on a LefSe analysis.  699 
A and C: Circular cladograms of statistically significant differences in the gut 700 
microbiota between the control and Al group at 8 and 24 h, respectively. In the panel, 701 
the diameters of the circles exhibit positive correlations with the relative abundances. 702 
Green, red, and yellow circles indicate microbial species that are significantly 703 
enriched in the control or Al group or are not significantly affected, respectively. p, 704 
phylum; c, class; o, order; f, family; g, genus. a and c: Histograms of LDA scores for 705 
statistically significant differences between the control group (green bars) and Al 706 
group (red bars) at 8 and 24 h, respectively. B and D: Circular cladograms comparing 707 
the Al group and Al + LP group at 8 and 24 h, respectively. b and d: Histograms for 708 
the Al group and Al + LP group at 8 and 24 h, respectively. 709 
 710 
Figure 6. Effects of Al and L. plantarum CCFM639 treatment on the relative 711 
abundances of specific gut bacteria.  712 
25 
 
Different letters indicate statistically significant changes among the four groups (P < 713 
0.05). 714 
 715 
Figure 7. Effects of Al exposure and L. plantarum CCFM639 on short-chain fatty 716 
acids based on metabolomic analysis.  717 
Letters (a-b and A-D) indicate statistically significant changes between the four 718 
groups at 8 and 24 h, respectively (P < 0.05). 719 
 720 
Figure 8. Correlation between abundances in the gut microbiota and changes in 721 
SCFAs.  722 
The colors and values indicate the distribution of Pearson’s correlation coefficients. 723 
Significant negative and positive correlations are represented by red and blue circles, 724 
respectively (P < 0.05). The intensity of the color represents the strength of the 725 
correlation. 726 
